131 related articles for article (PubMed ID: 38632691)
1. Nanoceria-Mediated Cyclosporin A Delivery for Dry Eye Disease Management through Modulating Immune-Epithelial Crosstalk.
Cui W; Chen S; Hu T; Zhou T; Qiu C; Jiang L; Cheng X; Ji J; Yao K; Han H
ACS Nano; 2024 Apr; 18(17):11084-11102. PubMed ID: 38632691
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage.
Xia Y; Zhang Y; Du Y; Wang Z; Cheng L; Du Z
J Nanobiotechnology; 2024 May; 22(1):233. PubMed ID: 38725011
[TBL] [Abstract][Full Text] [Related]
3. A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease.
Yu F; Zheng M; Zhang AY; Han Z
J Control Release; 2019 Dec; 315():40-54. PubMed ID: 31669212
[TBL] [Abstract][Full Text] [Related]
4. Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease.
Li YJ; Luo LJ; Harroun SG; Wei SC; Unnikrishnan B; Chang HT; Huang YF; Lai JY; Huang CC
Nanoscale; 2019 Mar; 11(12):5580-5594. PubMed ID: 30860532
[TBL] [Abstract][Full Text] [Related]
5. Melatonin ameliorates oxidative stress-mediated injuries through induction of HO-1 and restores autophagic flux in dry eye.
Wang B; Zuo X; Peng L; Wang X; Zeng H; Zhong J; Li S; Xiao Y; Wang L; Ouyang H; Yuan J
Exp Eye Res; 2021 Apr; 205():108491. PubMed ID: 33587908
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory and Antioxidative Effects of Camellia japonica on Human Corneal Epithelial Cells and Experimental Dry Eye: In Vivo and In Vitro Study.
Lee HS; Choi JH; Cui L; Li Y; Yang JM; Yun JJ; Jung JE; Choi W; Yoon KC
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1196-1207. PubMed ID: 28245300
[TBL] [Abstract][Full Text] [Related]
7. Anti-Oxidative and Anti-Inflammatory Micelles: Break the Dry Eye Vicious Cycle.
Li S; Lu Z; Huang Y; Wang Y; Jin Q; Shentu X; Ye J; Ji J; Yao K; Han H
Adv Sci (Weinh); 2022 Jun; 9(17):e2200435. PubMed ID: 35435328
[TBL] [Abstract][Full Text] [Related]
8. Dual-ROS-scavenging and dual-lingering nanozyme-based eye drops alleviate dry eye disease.
Zhang W; Zhao M; Chu D; Chen H; Cui B; Ning Q; Wang X; Li Z; Cao S; Li J
J Nanobiotechnology; 2024 May; 22(1):229. PubMed ID: 38720321
[TBL] [Abstract][Full Text] [Related]
9. A tissue-adhesive F127 hydrogel delivers antioxidative copper-selenide nanoparticles for the treatment of dry eye disease.
Ou L; Wu Z; Hu X; Huang J; Yi Z; Gong Z; Li H; Peng K; Shu C; Koole LH
Acta Biomater; 2024 Feb; 175():353-368. PubMed ID: 38110136
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive liposomal delivery system synergizing anti-inflammation and anti-oxidation for enhanced treatment against dry eye disease.
Huang K; Guo R; Luo H; Liu H; Chen D; Deng T; Li J; He J; Xu Z; Li M; He Q
J Control Release; 2024 Apr; 368():318-328. PubMed ID: 38428530
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of a pterostilbene-peptide prodrug nanomedicine for the management of dry eye.
Hu L; Hu Z; Yu Y; Ding X; Li K; Gong Q; Lin D; Dai M; Lu F; Li X
Int J Pharm; 2020 Oct; 588():119683. PubMed ID: 32712251
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic nanomaterials: Development of protein coated nanoceria as a potential antioxidative nano-agent for the effective scavenging of reactive oxygen species in vitro and in zebrafish model.
Bhushan B; Nandhagopal S; Rajesh Kannan R; Gopinath P
Colloids Surf B Biointerfaces; 2016 Oct; 146():375-86. PubMed ID: 27388966
[TBL] [Abstract][Full Text] [Related]
13. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice.
Hirst SM; Karakoti A; Singh S; Self W; Tyler R; Seal S; Reilly CM
Environ Toxicol; 2013 Feb; 28(2):107-18. PubMed ID: 21618676
[TBL] [Abstract][Full Text] [Related]
14. L-carnosine mitigates interleukin-1α-induced dry eye disease in rabbits via its antioxidant, anti-inflammatory, antiapoptotic, and antifibrotic effects.
Mousa AM; Aldebasi YH
Cutan Ocul Toxicol; 2021 Sep; 40(3):241-251. PubMed ID: 34056995
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A improves the hyperosmotic response in an experimental dry eye model by inhibiting the HMGB1/TLR4/NF-κB signaling pathway.
Shen J; Liang Y; Bi Z; Yin X; Chen C; Zhao X; Liu S; Li Y
Exp Eye Res; 2023 Apr; 229():109418. PubMed ID: 36806672
[TBL] [Abstract][Full Text] [Related]
16. Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease.
Žiniauskaitė A; Ragauskas S; Ghosh AK; Thapa R; Roessler AE; Koulen P; Kalesnykas G; Hakkarainen JJ; Kaja S
Ocul Surf; 2019 Apr; 17(2):257-264. PubMed ID: 30807830
[TBL] [Abstract][Full Text] [Related]
17. Nanoceria potently reduce superoxide fluxes from mitochondrial electron transport chain and plasma membrane NADPH oxidase in human macrophages.
Li YR; Zhu H
Mol Cell Biochem; 2021 Dec; 476(12):4461-4470. PubMed ID: 34478033
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.
Bang SP; Yeon CY; Adhikari N; Neupane S; Kim H; Lee DC; Son MJ; Lee HG; Kim JY; Jun JH
PLoS One; 2019; 14(11):e0224805. PubMed ID: 31738791
[TBL] [Abstract][Full Text] [Related]
19. Intracellular antioxidants dissolve man-made antioxidant nanoparticles: using redox vulnerability of nanoceria to develop a responsive drug delivery system.
Muhammad F; Wang A; Qi W; Zhang S; Zhu G
ACS Appl Mater Interfaces; 2014; 6(21):19424-33. PubMed ID: 25312332
[TBL] [Abstract][Full Text] [Related]
20. Dual-Atom Nanozyme Eye Drops Attenuate Inflammation and Break the Vicious Cycle in Dry Eye Disease.
Chu D; Zhao M; Rong S; Jhe W; Cai X; Xiao Y; Zhang W; Geng X; Li Z; Zhang X; Li J
Nanomicro Lett; 2024 Feb; 16(1):120. PubMed ID: 38372846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
